OrbiMed’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-133,200	Closed	-$2.37M	–	124
2024 Q2	$2.37M	Buy	+133,200	New	+$2.37M	0.05%	96
2023 Q3	–	Hold	0	–	–	–	130
2023 Q2	–	Hold	0	–	–	–	128